Click on image to view larger version.

Figure 1 Heart failure composite outcome (death, hospitalization, or discontinuation for worsening heart failure, heart failure classification, and/or global assessment score at eight months) (primary end point), Pediatric Carvedilol Study Group. p = 0.74 carvedilol combined versus placebo. Blue bars = improved; yellow bars = unchanged; green bars = worsened.